Estimation of groundwater storage from seismic data using deep learning

We investigate the feasibility of the use of convolutional neural networks to estimate the amount of groundwater stored in the aquifer and delineate water-table level from active-source seismic data. The seismic data to train and test the neural networks are obtained by solving wave propagation in a coupled poroviscoelastic-elastic media. A discontinuous Galerkin method is used to model wave propagation whereas a deep convolutional neural network is used for the parameter estimation problem. In the numerical experiment, the primary unknowns, the amount of stored groundwater and water-table level, are estimated, while the remaining parameters, assumed to be of less of interest, are successfully marginalized in the convolutional neural networks-based solution

Uncertainty-aware deep learning methods for robust diabetic retinopathy classification

Automatic classification of diabetic retinopathy from retinal images has been increasingly studied using deep neural networks with impressive results. However, there is clinical need for estimating uncertainty in the classifications, a shortcoming of modern neural networks. Recently, approximate Bayesian neural networks (BNNs) have been proposed for this task, but previous studies have only considered the binary referable/non-referable diabetic retinopathy classification applied to benchmark datasets. We present novel results for 9 BNNs by systematically investigating a clinical dataset and 5-class classification scheme, together with benchmark datasets and binary classification scheme. Moreover, we derive a connection between entropy-based uncertainty measure and classifier risk, from which we develop a novel uncertainty measure. We observe that the previously proposed entropy-based uncertainty measure improves performance on the clinical dataset for the binary classification scheme, but not to such an extent as on the benchmark datasets. It improves performance in the clinical 5-class classification scheme for the benchmark datasets, but not for the clinical dataset. Our novel uncertainty measure generalizes to the clinical dataset and to one benchmark dataset. Our findings suggest that BNNs can be utilized for uncertainty estimation in classifying diabetic retinopathy on clinical data, though proper uncertainty measures are needed to optimize the desired performance measure. In addition, methods developed for benchmark datasets might not generalize to clinical datasets

Uncertainty-Aware Deep Learning Methods for Robust Diabetic Retinopathy Classification

Funding Information: The work of Joel Jaskari, Jaakko Sahlsten, and Kimmo K. Kaski was supported in part by the Academy of Finland under Project 345449. Publisher Copyright: © 2013 IEEE.Automatic classification of diabetic retinopathy from retinal images has been increasingly studied using deep neural networks with impressive results. However, there is clinical need for estimating uncertainty in the classifications, a shortcoming of modern neural networks. Recently, approximate Bayesian neural networks (BNNs) have been proposed for this task, but previous studies have only considered the binary referable/non-referable diabetic retinopathy classification applied to benchmark datasets. We present novel results for 9 BNNs by systematically investigating a clinical dataset and 5-class classification scheme, together with benchmark datasets and binary classification scheme. Moreover, we derive a connection between entropy-based uncertainty measure and classifier risk, from which we develop a novel uncertainty measure. We observe that the previously proposed entropy-based uncertainty measure improves performance on the clinical dataset for the binary classification scheme, but not to such an extent as on the benchmark datasets. It improves performance in the clinical 5-class classification scheme for the benchmark datasets, but not for the clinical dataset. Our novel uncertainty measure generalizes to the clinical dataset and to one benchmark dataset. Our findings suggest that BNNs can be utilized for uncertainty estimation in classifying diabetic retinopathy on clinical data, though proper uncertainty measures are needed to optimize the desired performance measure. In addition, methods developed for benchmark datasets might not generalize to clinical datasets.Peer reviewe